GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade)

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?The last time I wrote about GSK plc ( GSK ) for Seeking Alpha, it was late September, and I was covering the news that its CEO since 2017, Emma Walmsley, was stepping away from theEdmund Ingham is a biotech consult ...